Catalyst Wire Dossier Catalyst Wire Dossier

43USSA1705

· Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 43USSA1705, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study for 43USSA1705 [NA]

See pricing